B16F10-hPD-L1
Strain Information
Validation Data
Figure 1. hPDL1 expression in B16F10-hPDL1 cell lines.
Figure 2. Tumor growth curve of B16F10-hPDL1 syngeneic model (n=5).
Figure 3. Body weight change of B16F10-hPDL1 syngeneic model (n=5).
Figure 4. The expression of hPDL1 in humanized modified tumors by FACS
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreAt GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
